Singleron Biotechnologies

Singleron Biotechnologies

Private
NanjingHealthcare & Life Scienceshttps://singleron.bio

Last Round

Series B

Nov 8, 2021

Total Funding Raised

$140M

Company Overview

Singleron Biotechnologies is a biotechnology company that provides single cell multi-omics solutions for clinical diagnosis, drug development, and health management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

single-cell analysissingle-cell multi-omicssingle-cell sequencingscRNA-seqbiotech equipmentsingle-cell sequencing servicesbioinformatics softwaremolecular diagnosticstranscriptome analysisdrug developmenttissue dissociationtissue preservationcontract research organizationCROprecision medicinemicrowell technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Singleron Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Singleron Biotechnologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BNov 8, 2021
Series A ExtensionNov 9, 2020
Series ASep 6, 2020
VC RoundJun 24, 2019

Key People

Founding team and executive leadership

Nan Fang

Founder, Chief Executive Officer, Chair Of Board

Founding Team

Singleron Biotechnologies Investors

Notable investors and investment history

InvestorRounds
CDH InvestmentsSeries A Extension, Series A, Series B
Lake Bleu CapitalSeries B
Firstred CapitalSeries B
MSA CapitalSeries B
ARCH Venture PartnersSeries A, Series B
CDG CapitalSeries A Extension, Series A, Series B
Sherpa Healthcare PartnersSeries A, Series B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2025

    Launched Tensor for single cell sequencing automation with Hamilton Bonaduz AG.

  • Apr 9, 2025

    Partnered with Hamilton Bonaduz AG to launch Tensor.

Singleron Biotechnologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Singleron Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Singleron Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range85
Year Founded2018
Last FundingNov 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.